Animal Vaccine Market
Animal Vaccine Market Study by Attenuated Live, Recombinant, DNA, Inactivated, and Subunit for Livestock Animals and Companion Animals from 2024 to 2034
Analysis of Animal/Veterinary Vaccine Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Animal Vaccine Market Outlook (2024 to 2034)
According to the recently revised analysis by Fact.MR, worldwide revenue from the sales of animal vaccines is calculated at US$ 15.62 billion for 2024. The Increasing prevalence of cattle and canine disorders is expected to drive global animal vaccine market growth at a CAGR of 9.1% to reach US$ 37.42 billion by 2034.
Rising investments in research and development initiatives by respective governments across the globe is positively influencing the demand for animal vaccines. In the recent past, there have been numerous instances of outbreaks of various contagious diseases, both among animals as well as their transmission to humans. Hence, emphasis on the development of advanced animal vaccines is gaining a major importance.
- Centers for Disease Control and Prevention estimates that zoonotic is a prevalent disease across the globe and more than 6 out of 10 known contagious (infectious) diseases and 3 out of 4 new diseases are transmitted into humans from animals.
The recent COVID-19 pandemic can be purported to be an end product of zoonotic viral transmission. Given the fact that the novel coronavirus originated from bats, veterinarians were emphasizing on inoculating animal populations against the virus as well. This significantly widened growth prospects for the industry during this crisis. Coronavirus also infected the mink farms across Europe which further highlighted the need for introducing advanced animal vaccines. Thus, Corona can be concluded as a major booster leading to innovations in the animal vaccine sector.
Manufacturers of animal vaccines are also focusing more on creating awareness regarding the importance of animal vaccination. As the global food industry heavily relies on animals for milk and meat, the demand for various vaccines such as autogenous, flu, and aquaculture is expected to grow.
- The North American animal vaccine market size is projected to reach US$ 15.35 billion by 2034.
- Western Europe is estimated to hold 21% of the global animal vaccine market share in 2024.
Report Attributes | Details |
---|---|
Animal Vaccine Market Size (2024E) | US$ 15.62 Billion |
Forecasted Market Value (2034F) | US$ 37.42 Billion |
Global Market Growth Rate (2024 to 2034) | 9.1% CAGR |
South Korea Market Value (2024E) | US$ 610.6 Million |
South Asia & Pacific Market Share (2034F) | 22.6% |
Subcutaneous Administration Type Vaccine Demand Growth Rate (2024 to 2034) | 9.5% CAGR |
Key Companies Profiled | Merck & Co. Inc.; Virbac; Biogenesis Bago; Indian Immunologicals Ltd.; CEVA Animal Health (Pty) Ltd.; Phibro Animal Health Corporation; Zoetis Inc.; NEOGEN Corporation; Boehringer Ingelheim International GmbH; Elanco Animal Health Incorporated |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Aspects are Pushing Demand for Animal Vaccines?
“Increasing Livestock Production Driving Need for Improved Vaccinations”
Growing livestock population and surge in the cattle diseases are some of the notable animal vaccine market trends. Animals are a vital source of milk, meat, food, protein, and other commercial products such as leather and wool, which necessitates a need to keep a track on their health.
Rabies, equine influenza virus and foot and mouth diseases are some of the prevalent animal disorders boosting the need for effective vaccines. Manufacturers are concentrating on producing effective vaccines that help in preventing the transmission of infectious agents in animals.
Rising food security concerns and increasing animal husbandry sector is escalating the demand for animal vaccines for the livestock population. Furthermore, the growing demand for animal products for food and clothing are boosting the growth in livestock production globally. Variation in food preferences due to changing lifestyles and population growth are also some of the other factors increasing the demand for livestock products, driving animal vaccine sales.
“Rising Prevalence of Contagious Diseases Bolstering Consumption of Animal Vaccines”
Emerging zoonotic diseases of both companion and livestock animals are a major threat to public health. The rising prevalence of zoonotic and other infectious diseases is potentially boosting the demand for next-gen animal vaccines. Zoonotic disease can be transmitted to humans, this risk is further leading to the production of advanced vaccines. In addition, the rapidly growing pet culture across the globe is contributing to the growth of emerging and exotic animal diseases creating ample opportunities for animal vaccine producers
Rising demand for animal protein is also contributing to high commercial animal food production. Furthermore, the possibility of world experiencing emerging disease outbreaks is high. Thus, the awareness for vaccinating animals is increasing.
What’s Hurting Revenue Growth of Animal Vaccine Producers?
“Lack of Awareness and Accessibility Primarily Hampering Widespread Adoption of Animal Immunizations”
Even though sales of animal vaccines are gaining traction, lack of awareness around some regions or among small scale animal farm holders is expected to lower their widespread adoption. The small scale animal farm holders might also deter the immunizations of animals due to high costs of vaccines or lack of accessibility. Several organizations and manufacturers across the globe are focusing on various tactics to increase adoption of animal vaccines, to boost their accessibility, and awareness.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Is Animal Vaccine Production a Profitable Business to Invest in for New Companies?
“Focus on Product Innovation and Differentiation Will Boost Market Reach”
Veterinary vaccine industry is witnessing a substantial rise in technological advancements. Recombinant DNA technology is one of the leading developments in the market. New companies entering the market should focus on innovations to succeed for long run. Innovations such as the development of plant-based vaccines are expected to show several advantages compared to conventional ones. Product innovations aid start-ups to build their position in the market. This also helps to attract a wider consumer base.
Country-wise Analysis
Why is the United States a Prime Market for Animal Vaccine Suppliers?
“Ongoing Developments in Veterinary Vaccines Set to Offer Lucrative Business Opportunities”
Attribute | United States |
---|---|
Market Value (2024E) | US$ 5.1 Billion |
Growth Rate (2024 to 2034) | 9.7% CAGR |
Projected Value (2034F) | US$ 12.86 Billion |
The United States is the one of the most profitable markets for animal vaccine producers due to the presence of strong animal husbandry sector. The surge in pet culture, advancements in pet vaccines, and growing investments in the production of advanced vaccine delivery methods is expected to boost the market growth in the United States. Thus, advancements in veterinary science and biotechnology are set to boost the sales of animal vaccines in the United States.
What is the Demand Outlook for Animal Vaccines in Germany?
“Rising Pet Culture Increasing Consumption of Companion Animal Vaccines”
Germany is one of the high-growth potential markets in European region. This can be due to the presence of advanced pharmaceutical sector and advanced healthcare infrastructure. The country is also well known for extensive scientific research and innovations. The rising pet culture and growing prevalence of companion animal diseases is fuelling the demand for effective veterinary vaccines in Germany.
- According to Statista report 2022, around 24% of Germans owned cats, 21% owned dogs, while 5% owned small animals.
What’s Driving Sales of Animal Vaccines in India?
“Presence of Robust Animal Husbandry and Commercial Aquaculture Sectors”
Attribute | India |
---|---|
Market Value (2024E) | US$ 882.2 Million |
Growth Rate (2024 to 2034) | 14.1% CAGR |
Projected Value (2034F) | US$ 3.3 Billion |
India is a large market for animal vaccines in South Asia & Pacific region due to the presence of robust animal farming sector. Several government initiatives positively supporting the animal husbandry and commercial aquaculture sectors are creating ample opportunities for animal vaccine providers.
- According to the Indian government, the country is the largest producer of milk across the globe.
Thus, ever-growing dairy sector and surge in the cattle production are contributing to animal vaccine market growth in India.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Analysis
Which Animal Category Accounts for High Usage of Vaccines?
“Rising Livestock Production Increasing Consumption of Animal Vaccines”
Attribute | Livestock Animal Vaccines |
---|---|
Segment Value (2024E) | US$ 10.23 Billion |
Growth Rate (2024 to 2034) | 8.9% CAGR |
Projected Value (2034F) | US$ 24.04 Billion |
Rising livestock population particularly cattle, pig, poultry, and sheep across the globe are contributing to the outbreak of diseases. Farm holders are widely focusing on livestock production due to the increasing demand for milk, meat, protein, wool, and leather. Proper care for healthy growth of animals is leading to the increasing consumption of vaccines.
Respective governments across the globe are offering various initiatives supporting the awareness of animal vaccinations. Increasing prevalence rate of E.coli in various cattle categories is also boosting the demand for animal vaccines.
Which Vaccine Type is Most Widely Popular across the World?
“Long-Lasting Effect and Reduction in Mortality Rates Due to Attenuated Live Vaccines”
Attribute | Attenuated Live Vaccines |
---|---|
Segment Value (2024E) | US$ 5.49 Billion |
Growth Rate (2024 to 2034) | 9.4% CAGR |
Projected Value (2034F) | US$ 13.43 Billion |
Live attenuation is not only the oldest vaccination method used in the veterinary field but now is also being used under trial for the development of additional applications. Thus, these products help in reducing the mortality rate by improving the life span of disease-affected animals. Attenuated live vaccines are more effective as they provides prolong protection against the infections.
Competitive Landscape
Key players in the animal vaccine market are capitalizing on respective governments supportive polices and initiatives across the globe to promote animal health. This support is contributing to the production of next-gen vaccine formulations against a wide variety of pathogens. Furthermore, industry leaders are also emphasizing on global expansions, mergers, acquisitions and collaborations to achieve a competitive edge.
- In August 2020, Merck & Co., Inc. completed the acquisition of IdentiGEN. The company is focusing on studying DNA of animals for livestock. Through this acquisition, Merck intends to provide complete transparency to food processors, producers and retailers, regarding animal traceability solutions to ensure that good quality food is available to consumers.
Key Segments of Animal Vaccine Market Research
-
By Product :
- Attenuated Live
- Recombinant
- DNA
- Inactivated
- Subunit
-
By Animal Type :
- Livestock Animal Vaccines
- Companion Animal Vaccines
-
By Route of Administration :
- Subcutaneous Administration
- Intranasal Administration
- Intramuscular Administration
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background
- 5. Key Success Factors
- 6. Global Market Demand Analysis 2019 to 2023 and Forecast, 2024 to 2034
- 7. Global Market Value Analysis 2019 to 2023 and Forecast, 2024 to 2034
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
- 8.1. Attenuated Live Vaccines
- 8.2. Inactivated Vaccines
- 8.3. Subunit Vaccines
- 8.4. DNA Vaccines
- 8.5. Recombinant Vaccines
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Animal Type
- 9.1. Livestock
- 9.1.1. Poultry
- 9.1.2. Aqua
- 9.1.3. Ruminants
- 9.1.4. Swine
- 9.2. Companion
- 9.2.1. Canine
- 9.2.2. Feline
- 9.2.3. Others
- 9.1. Livestock
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration
- 10.1. Subcutaneous
- 10.2. Intramuscular
- 10.3. Intranasal
- 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. Asia Pacific
- 11.5. Middle East and Africa (MEA)
- 12. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 13. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 14. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 15. Asia Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 17. Key Countries Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 18. Market Structure Analysis
- 19. Competition Analysis
- 19.1. Merck & Co., Inc.
- 19.2. Zoetis
- 19.3. Boehringer Ingelheim International GmbH
- 19.4. Virbac
- 19.5. Biogénesis Bagó
- 19.6. Indian Immunologicals Ltd.
- 19.7. Elanco
- 19.8. Ceva
- 19.9. Phibro Animal Health Corporation
- 19.10. Neogen Corporation
- 20. Assumptions and Acronyms Used
- 21. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn), By Product, 2019 to 2023
Table 02: Global Market Value (US$ Mn), By Product, 2024 to 2034
Table 03: Global Market Value (US$ Mn), By Route of Administration, 2019 to 2023
Table 04: Global Market Value (US$ Mn), By Route of Administration, 2024 to 2034
Table 05: Global Market Value (US$ Mn), By Animal Type, 2019 to 2023
Table 06: Global Market Value (US$ Mn), By Animal Type, 2024 to 2034
Table 07: Global Market, By Region, 2019 to 2023
Table 08: Global Market, By Region, 2024 to 2034
Table 09: North America Market Value (US$ Mn), By Product, 2019 to 2023
Table 10: North America Market Value (US$ Mn), By Product, 2024 to 2034
Table 11: North America Market Value (US$ Mn), By Route of Administration, 2019 to 2023
Table 12: North America Market Value (US$ Mn), By Route of Administration, 2024 to 2034
Table 13: North America Market Value (US$ Mn), By Animal Type, 2019 to 2023
Table 14: North America Market Value (US$ Mn), By Animal Type, 2024 to 2034
Table 15: North America Market, By Country, 2019 to 2023
Table 16: North America Market, By Country, 2024 to 2034
Table 17: Latin America Market Value (US$ Mn), By Product, 2019 to 2023
Table 18: Latin America Market Value (US$ Mn), By Product, 2024 to 2034
Table 19: Latin America Market Value (US$ Mn), By Route of Administration, 2019 to 2023
Table 20: Latin America Market Value (US$ Mn), By Route of Administration, 2024 to 2034
Table 21: Latin America Market Value (US$ Mn), By Animal Type, 2019 to 2023
Table 22: Latin America Market Value (US$ Mn), By Animal Type, 2024 to 2034
Table 23: Latin America Market, By Country, 2019 to 2023
Table 24: Latin America Market, By Country, 2024 to 2034
Table 25: Europe Market Value (US$ Mn), By Product, 2019 to 2023
Table 26: Europe Market Value (US$ Mn), By Product, 2024 to 2034
Table 27: Europe Market Value (US$ Mn), By Route of Administration, 2019 to 2023
Table 28: Europe Market Value (US$ Mn), By Route of Administration, 2024 to 2034
Table 29: Europe Market Value (US$ Mn), By Animal Type, 2019 to 2023
Table 30: Europe Market Value (US$ Mn), By Animal Type, 2024 to 2034
Table 31: Europe Market, By Country, 2019 to 2023
Table 32: Europe Market, By Country, 2024 to 2034
Table 33: Asia Pacific Market Value (US$ Mn), By Product, 2019 to 2023
Table 34: Asia Pacific Market Value (US$ Mn), By Product, 2024 to 2034
Table 35: Asia Pacific Market Value (US$ Mn), By Route of Administration, 2019 to 2023
Table 36: Asia Pacific Market Value (US$ Mn), By Route of Administration, 2024 to 2034
Table 37: Asia Pacific Market Value (US$ Mn), By Animal Type, 2019 to 2023
Table 38: Asia Pacific Market Value (US$ Mn), By Animal Type, 2024 to 2034
Table 39: Asia Pacific Market, By Country, 2019 to 2023
Table 40: Asia Pacific Market, By Country, 2024 to 2034
Table 41: MEA Market Value (US$ Mn), By Product, 2019 to 2023
Table 42: MEA Market Value (US$ Mn), By Product, 2024 to 2034
Table 43: MEA Market Value (US$ Mn), By Route of Administration, 2019 to 2023
Table 44: MEA Market Value (US$ Mn), By Route of Administration, 2024 to 2034
Table 45: MEA Market Value (US$ Mn), By Animal Type, 2019 to 2023
Table 46: MEA Market Value (US$ Mn), By Animal Type, 2024 to 2034
Table 47: MEA Market, By Country, 2019 to 2023
Table 48: MEA Market, By Country, 2024 to 2034
Table 49: Global Market Incremental $ Opportunity, By Product, 2019 to 2023
Table 50: Global Market Incremental $ Opportunity, By Route of Administration, 2024 to 2034
Table 51: Global Market Incremental $ Opportunity, By Animal Type, 2019 to 2023
Table 52: Global Market Incremental $ Opportunity, By Region, 2024 to 2034
Table 53: North America Market Incremental $ Opportunity, By Product, 2019 to 2023
Table 54: North America Market Incremental $ Opportunity, By Route of Administration, 2024 to 2034
Table 55: North America Market Incremental $ Opportunity, By Animal Type, 2019 to 2023
Table 56: North America Market Incremental $ Opportunity, By Country, 2024 to 2034
Table 57: Latin America Market Incremental $ Opportunity, By Product, 2019 to 2023
Table 58: Latin America Market Incremental $ Opportunity, By Route of Administration, 2024 to 2034
Table 59: Latin America Market Incremental $ Opportunity, By Animal Type, 2019 to 2023
Table 60: Latin America Market Incremental $ Opportunity, By Country, 2024 to 2034
Table 61: Europe Market Incremental $ Opportunity, By Product, 2019 to 2023
Table 62: Europe Market Incremental $ Opportunity, By Route of Administration, 2024 to 2034
Table 63: Europe Market Incremental $ Opportunity, By Animal Type, 2019 to 2023
Table 64: Europe Market Incremental $ Opportunity, By Country, 2024 to 2034
Table 65: Asia Pacific Market Incremental $ Opportunity, By Product, 2019 to 2023
Table 66: Asia Pacific Market Incremental $ Opportunity, By Route of Administration, 2024 to 2034
Table 67: Asia Pacific Market Incremental $ Opportunity, By Animal Type, 2019 to 2023
Table 68: Asia Pacific Market Incremental $ Opportunity, By Country, 2024 to 2034
Table 69: MEA Market Incremental $ Opportunity, By Product, 2019 to 2023
Table 70: MEA Market Incremental $ Opportunity, By Route of Administration, 2024 to 2034
Table 71: MEA Market Incremental $ Opportunity, By Animal Type, 2019 to 2023
Table 72: MEA Market Incremental $ Opportunity, By Country, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) and Year-on-Year Growth, 2019 to 2034
Figure 02: Global Market Absolute $ Historical Gain (2015 to 2023) and Opportunity (2024 to 2034), US$ Mn
Figure 03: Global Market Share, By Product, 2024 & 2034
Figure 04: Global Market Y-o-Y Growth Projections, By Product - 2024 to 2034
Figure 05: Global Market Attractiveness Index, By Product - 2024 to 2034
Figure 06: Global Market Share, By Route of Administration, 2024 & 2034
Figure 07: Global Market Y-o-Y Growth Projections, By Route of Administration - 2024 to 2034
Figure 08: Global Market Attractiveness Index, By Route of Administration - 2024 to 2034
Figure 09: Global Market Share, By Animal Type, 2024 & 2034
Figure 10: Global Market Y-o-Y Growth Projections, By Animal Type - 2024 to 2034
Figure 11: Global Market Attractiveness Index, By Animal Type - 2024 to 2034
Figure 12: Global Market Share, By Region, 2024 & 2034
Figure 13: Global Market Y-o-Y Growth Projections, By Region - 2024 to 2034
Figure 14: Global Market Attractiveness Index, By Region - 2024 to 2034
Figure 15: North America Market Value (US$ Mn) and Year-on-Year Growth, 2019 to 2034
Figure 16: North America Market Absolute $ Opportunity Historical (2015 to 2023) and Forecast Period (2024 to 2034), US$ Mn
Figure 17: North America Market Share, By Product, 2024 & 2034
Figure 18: North America Market Y-o-Y Growth Projections, By Product - 2024 to 2034
Figure 19: North America Market Attractiveness Index, By Product - 2024 to 2034
Figure 20: North America Market Share, By Route of Administration, 2024 & 2034
Figure 21: North America Market Y-o-Y Growth Projections, By Route of Administration - 2024 to 2034
Figure 22: North America Market Attractiveness Index, By Route of Administration - 2024 to 2034
Figure 23: North America Market Share, By Animal Type, 2024 & 2034
Figure 24: North America Market Y-o-Y Growth Projections, By Animal Type - 2024 to 2034
Figure 25: North America Market Attractiveness Index, By Animal Type - 2024 to 2034
Figure 26: North America Market Share, By Country, 2024 & 2034
Figure 27: North America Market Y-o-Y Growth Projections, By Country - 2024 to 2034
Figure 28: North America Market Attractiveness Index, By Country - 2024 to 2034
Figure 29: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2019 to 2034
Figure 30: Latin America Market Absolute $ Opportunity Historical (2015 to 2023) and Forecast Period (2024 to 2034), US$ Mn
Figure 31: Latin America Market Share, By Product, 2024 & 2034
Figure 32: Latin America Market Y-o-Y Growth Projections, By Product - 2024 to 2034
Figure 33: Latin America Market Attractiveness Index, By Product - 2024 to 2034
Figure 34: Latin America Market Share, By Route of Administration, 2024 & 2034
Figure 35: Latin America Market Y-o-Y Growth Projections, By Route of Administration - 2024 to 2034
Figure 36: Latin America Market Attractiveness Index, By Route of Administration - 2024 to 2034
Figure 37: Latin America Market Share, By Animal Type, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projections, By Animal Type - 2024 to 2034
Figure 39: Latin America Market Attractiveness Index, By Animal Type - 2024 to 2034
Figure 40: Latin America Market Share, By Country, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections, By Country - 2024 to 2034
Figure 42: Latin America Market Attractiveness Index, By Country - 2024 to 2034
Figure 43: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2019 to 2034
Figure 44: Europe Market Absolute $ Opportunity Historical (2015 to 2023) and Forecast Period (2024 to 2034), US$ Mn
Figure 45: Europe Market Share, By Product, 2024 & 2034
Figure 46: Europe Market Y-o-Y Growth Projections, By Product - 2024 to 2034
Figure 47: Europe Market Attractiveness Index, By Product - 2024 to 2034
Figure 48: Europe Market Share, By Route of Administration, 2024 & 2034
Figure 49: Europe Market Y-o-Y Growth Projections, By Route of Administration - 2024 to 2034
Figure 50: Europe Market Attractiveness Index, By Route of Administration - 2024 to 2034
Figure 51: Europe Market Share, By Animal Type, 2024 & 2034
Figure 52: Europe Market Y-o-Y Growth Projections, By Animal Type - 2024 to 2034
Figure 53: Europe Market Attractiveness Index, By Animal Type - 2024 to 2034
Figure 54: Europe Market Share, By Country, 2024 & 2034
Figure 55: Europe Market Y-o-Y Growth Projections, By Country - 2024 to 2034
Figure 56: Europe Market Attractiveness Index, By Country - 2024 to 2034
Figure 57: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2019 to 2034
Figure 58: MEA Market Absolute $ Opportunity Historical (2015 to 2023) and Forecast Period (2024 to 2034), US$ Mn
Figure 59: MEA Market Share, By Product, 2024 & 2034
Figure 60: MEA Market Y-o-Y Growth Projections, By Product - 2024 to 2034
Figure 61: MEA Market Attractiveness Index, By Product - 2024 to 2034
Figure 62: MEA Market Share, By Route of Administration, 2024 & 2034
Figure 63: MEA Market Y-o-Y Growth Projections, By Route of Administration - 2024 to 2034
Figure 64: MEA Market Attractiveness Index, By Route of Administration - 2024 to 2034
Figure 65: MEA Market Share, By Animal Type, 2024 & 2034
Figure 66: MEA Market Y-o-Y Growth Projections, By Animal Type - 2024 to 2034
Figure 67: MEA Market Attractiveness Index, By Animal Type - 2024 to 2034
Figure 68: MEA Market Share, By Country, 2024 & 2034
Figure 69: MEA Market Y-o-Y Growth Projections, By Country - 2024 to 2034
Figure 70: MEA Market Attractiveness Index, By Country - 2024 to 2034
Figure 71: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2019 to 2034
Figure 72: Asia Pacific Market Absolute $ Opportunity Historical (2015 to 2023) and Forecast Period (2024 to 2034), US$ Mn
Figure 73: Asia Pacific Market Share, By Product, 2024 & 2034
Figure 74: Asia Pacific Market Y-o-Y Growth Projections, By Product - 2024 to 2034
Figure 75: Asia Pacific Market Attractiveness Index, By Product - 2024 to 2034
Figure 76: Asia Pacific Market Share, By Route of Administration, 2024 & 2034
Figure 77: Asia Pacific Market Y-o-Y Growth Projections, By Route of Administration - 2024 to 2034
Figure 78: Asia Pacific Market Attractiveness Index, By Route of Administration - 2024 to 2034
Figure 79: Asia Pacific Market Share, By Animal Type, 2024 & 2034
Figure 80: Asia Pacific Market Y-o-Y Growth Projections, By Animal Type - 2024 to 2034
Figure 81: Asia Pacific Market Attractiveness Index, By Animal Type - 2024 to 2034
Figure 82: Asia Pacific Market Share, By Country, 2024 & 2034
Figure 83: Asia Pacific Market Y-o-Y Growth Projections, By Country - 2024 to 2034
Figure 84: Asia Pacific Market Attractiveness Index, By Country - 2024 to 2034
Figure 85: US Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 86: US Market Share, By Product, 2023
Figure 87: US Market Share, By Route of Administration, 2023
Figure 88: US Market Share, By Animal Type, 2023
Figure 89: Canada Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 90: Canada Market Share, By Product, 2023
Figure 91: Canada Market Share, By Route of Administration, 2023
Figure 92: Canada Market Share, By Animal Type, 2023
Figure 93: Brazil Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 94: Brazil Market Share, By Product, 2023
Figure 95: Brazil Market Share, By Route of Administration, 2023
Figure 96: Brazil Market Share, By Animal Type, 2023
Figure 97: Mexico Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 98: Mexico Market Share, By Product, 2023
Figure 99: Mexico Market Share, By Route of Administration, 2023
Figure 100: Mexico Market Share, By Animal Type, 2023
Figure 101: Germany Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 102: Germany Market Share, By Product, 2023
Figure 103: Germany Market Share, By Route of Administration, 2023
Figure 104: Germany Market Share, By Animal Type, 2023
Figure 105: U.K. Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 106: U.K. Market Share, By Product, 2023
Figure 107: U.K. Market Share, By Route of Administration, 2023
Figure 108: U.K. Market Share, By Animal Type, 2023
Figure 109: France Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 110: France Market Share, By Product, 2023
Figure 111: France Market Share, By Route of Administration, 2023
Figure 112: France Market Share, By Animal Type, 2023
Figure 113: Italy Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 114: Italy Market Share, By Product, 2023
Figure 115: Italy Market Share, By Route of Administration, 2023
Figure 116: Italy Market Share, By Animal Type, 2023
Figure 117: BENELUX Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 118: BENELUX Market Share, By Product, 2023
Figure 119: BENELUX Market Share, By Route of Administration, 2023
Figure 120: BENELUX Market Share, By Animal Type, 2023
Figure 121: Nordic Countries Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 122: Nordic Countries Market Share, By Product, 2023
Figure 123: Nordic Countries Market Share, By Route of Administration, 2023
Figure 124: Nordic Countries Market Share, By Animal Type, 2023
Figure 125: China Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 126: China Market Share, By Product, 2023
Figure 127: China Market Share, By Route of Administration, 2023
Figure 128: China Market Share, By Animal Type, 2023
Figure 129: Japan Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 130: Japan Market Share, By Product, 2023
Figure 131: Japan Market Share, By Route of Administration, 2023
Figure 132: Japan Market Share, By Animal Type, 2023
Figure 133: South Korea Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 134: South Korea Market Share, By Product, 2023
Figure 135: South Korea Market Share, By Route of Administration, 2023
Figure 136: South Korea Market Share, By Animal Type, 2023
Figure 137: GCC Countries Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 138: GCC Countries Market Share, By Product, 2023
Figure 139: GCC Countries Market Share, By Route of Administration, 2023
Figure 140: GCC Countries Market Share, By Animal Type, 2023
Figure 141: South Africa Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 142: South Africa Market Share, By Product, 2023
Figure 143: South Africa Market Share, By Route of Administration, 2023
Figure 144: South Africa Market Share, By Animal Type, 2023
Figure 145: Turkey Market Value (US$ Mn) and Forecast, 2024 to 2034
Figure 146: Turkey Market Share, By Product, 2023
Figure 147: Turkey Market Share, By Route of Administration, 2023
Figure 148: Turkey Market Share, By Animal Type, 2023
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the animal vaccine market in 2024?
The global animal vaccine market is evaluated at US$ 15.62 billion in 2024.
What is the projected size of the animal vaccine market for 2034?
Sales of animal vaccines are forecasted to reach US$ 37.42 billion by 2034.
What is the estimated demand growth for animal vaccines?
Demand for animal vaccines is projected to rise at a CAGR of 9.1% through 2034.
Which East Asian country is an emerging market for animal vaccines?
South Korea is projected to account for 24.4% of the East Asia market share by 2034.
Which animal vaccine is most widely demanded?
Sales of livestock animal vaccines are forecasted to reach US$ 24.04 billion by 2034.
Who are the leading producers of animal vaccines?
Some of the prime manufacturers are Merck & Co. Inc., Zoetis Inc., and Boehringer Ingelheim International GmbH.